STIM
Neuronetics, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website neurostar.com
- Employees(FY) 211
- ISIN US64131A1051
Performance
+19.83%
1W
+84.06%
1M
+46.72%
3M
-23.63%
6M
-52.07%
YTD
-47.55%
1Y
Profile
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Technical Analysis of STIM 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-18 03:30
- 2024-12-16 03:30
- 2024-12-09 21:00
- 2024-11-19 19:30
- 2024-11-12 13:10
- 2024-11-12 05:45
- 2024-11-12 03:30
- 2024-11-11 19:20
Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates(Yahoo Finance)
- 2024-11-11 18:19
Neuronetics: Q3 Earnings Snapshot(Yahoo Finance)
- 2024-11-11 18:10
- 2024-11-10 18:26
- 2024-10-29 04:30
- 2024-10-13 20:31
- 2024-10-03 20:33
- 2024-09-24 20:31
- 2024-09-18 20:31
- 2024-09-15 20:32
NeuroStar Releases Software Upgrades to Elevate Patient Care(Globenewswire)
- 2024-09-02 20:29
- 2024-08-19 20:29
- 2024-08-14 17:42
- 2024-08-13 00:56
- 2024-08-13 00:47
- 2024-08-12 21:45
- 2024-08-11 20:25
Neuronetics (STIM) Reports Q2 Loss, Lags Revenue Estimates(Yahoo Finance)
- 2024-08-11 19:19
Neuronetics: Q2 Earnings Snapshot(Yahoo Finance)
- 2024-08-11 19:15
- 2024-08-11 19:10
- 2024-08-05 04:36
- 2024-07-31 20:29
- 2024-07-30 20:30
Page 1 of 6
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.